about
Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer.Prognostic significance of MYH9 expression in resected non-small cell lung cancer.Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance.Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based ProteomicsS100A16 is a Prognostic Marker for Lung Adenocarcinomas.Calnexin is a novel sero-diagnostic marker for lung cancer.Acquisition of useful sero-diagnostic autoantibodies using the same patients'sera and tumor tissues.Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma.Prognostic significance of S100A16 sub-cellular localization in lung adenocarcinoma.Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas.Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladderProteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis
P50
Q35138712-3D283FAC-AA0C-4CAA-89A5-F568FE86F901Q35235225-43FFB627-9D67-4B0B-949A-0378B0D2527DQ35561885-DE685D84-4094-4588-B885-F68EE1DBFE6AQ36118351-3735F62C-B1BF-4140-B904-3ED1FBD740DFQ38823896-4CF3ABF5-EFC6-4ABE-8D2D-D087BC795BCCQ38837389-DB7A97EB-E781-4DA2-9524-419A5702D50BQ39001704-7788A6FC-8102-45D2-BFF3-7F263546F186Q39377757-7162DCE2-832C-40CB-815C-68D2C7BBFC77Q46581458-551B2204-CDDB-4735-868F-85BEC6A21E9AQ47213406-E1A1A975-751A-4A26-B7E1-3BF151F11013Q47761566-F531E493-43CB-41BC-8791-46252E6D7100Q47948390-DE720D27-994F-4E19-9FCA-872819F18635Q50068808-CB6DF9C1-E52C-4C4D-99AA-E13B0B23C346Q51550264-CADA97ED-60E8-4699-BD82-B55BBDAB4C96Q86874315-AB20439C-7E75-450B-8EAF-88AEAA809540Q89860448-0953A82B-5A23-4B2B-8296-E894F4AC893A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7176-7207
@en
name
Makoto Kobayashi
@ast
Makoto Kobayashi
@en
Makoto Kobayashi
@es
Makoto Kobayashi
@nl
type
label
Makoto Kobayashi
@ast
Makoto Kobayashi
@en
Makoto Kobayashi
@es
Makoto Kobayashi
@nl
prefLabel
Makoto Kobayashi
@ast
Makoto Kobayashi
@en
Makoto Kobayashi
@es
Makoto Kobayashi
@nl
P106
P31
P496
0000-0001-7176-7207